Skip to content
Research Article Open access CC BY 4.0

Overview of CRISPR-Cas Mediated Genome Engineering

T. G. Bhuvana, N. Ranjitha

Journal of Applied Life Sciences International · pp. 37–46 · Published 1 Nov 2022

10.9734/jalsi/2022/v25i6583

Abstract

Genetic diseases are prevailing in 3-5% of new-born worldwide and estimated to cause around 50% of child deaths. The development of efficient and regulated system for customizing genome modifications to treat such disorders has been the zone of interest. Over time, different editing techniques have emerged based on programmable nucleases such as ZFN or TALENS but among all, CRISPR-Cas has significantly progressed as alteration tool from bench to clinical practices. CRISPR-Cas is an immune system discovered in prokaryotes that enables organism to recognize and destroy any invading genetic elements. This functional property of CRISPR has opened up plethora of applications across different disciplines such as diagnostics, agriculture and therapeutics. So here, the review attempt to discuss origin, mechanisms pertinent to CRISPR and applications along with challenges concerning them.

Genome editing CRISPR-Cas genetic disorder disease model agriculture bioenergy therapeutics

References (52)

  1. 1 Development and Applications of CRISPR-Cas9 for Genome Engineering [DOI]
  2. 2 Search-and-replace genome editing without double-strand breaks or donor DNA [DOI]
  3. 3 An updated evolutionary classification of CRISPR–Cas systems [DOI]
  4. 4 Evolution and classification of the CRISPR–Cas systems [DOI]
  5. 5 CRISPR/Cas, the Immune System of Bacteria and Archaea [DOI]
  6. 6 Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects [DOI]
  7. 7 CRISPR-engineered T cells in patients with refractory cancer [DOI]
  8. 8 Diversity, classification and evolution of CRISPR-Cas systems [DOI]
  9. 9 The American Association for the Advancement of Science [DOI]
  10. 10 Applications of CRISPR–Cas in agriculture and plant biotechnology [DOI]
  11. 11 A light-inducible CRISPR-Cas9 system for control of endogenous gene activation [DOI]
  12. 12 Photoactivatable CRISPR-Cas9 for optogenetic genome editing [DOI]
  13. 13 The CRISPR-Cas immune system: Biology, mechanisms and applications [DOI]
  14. 14 Genome Engineering Using CRISPR-Cas9 System [DOI]
  15. 15 CRISPR-Cas: biology, mechanisms and relevance [DOI]
  16. 16 Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing [DOI]
  17. 17 Applications of the CRISPR–Cas9 system in cancer biology [DOI]
  18. 18 CRISPR-Cas9 system: A new-fangled dawn in gene editing [DOI]
  19. 19 CRISPR/Cas9 for cancer research and therapy [DOI]
  20. 20 Optical Control of CRISPR/Cas9 Gene Editing [DOI]
  21. 21 Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks [DOI]
  22. 22 Molecular Mechanisms of CRISPR-Cas Immunity in Bacteria [DOI]
  23. 23 Engineering crops of the future: CRISPR approaches to develop climate-resilient and disease-resistant plants [DOI]
  24. 24 Recent advances in the CRISPR genome editing tool set [DOI]
  25. 25 Application of different types of CRISPR/Cas-based systems in bacteria [DOI]
  26. 26 CRISPR–Cas: a tool for cancer research and therapeutics [DOI]
  27. 27 Recent Progress in CRISPR/Cas9 Technology [DOI]
  28. 28 CRISPR-Cas Biology and Its Application to Infectious Diseases [DOI]
  29. 29 Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine [DOI]
  30. 30 Current situation of biofuel production and its enhancement by CRISPR/Cas9-mediated genome engineering of microbial cells [DOI]
  31. 31 Base and Prime Editing Technologies for Blood Disorders [DOI]
  32. 32 Methods and applications of CRISPR/Cas system for genome editing in stem cells [DOI]
  33. 33 Applications of CRISPR-Cas9 as an Advanced Genome Editing System in Life Sciences [DOI]
  34. 34 A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells [DOI]
  35. 35 CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges [DOI]
  36. 36 CRISPR: History and perspectives to the future [DOI]
  37. 37 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics [DOI]
  38. 38 CRISPR History: Discovery, Characterization, and Prosperity [DOI]
  39. 39 Applications of the CRISPR/Cas system beyond gene editing [DOI]
  40. 40 Stem Cell-Based Disease Modeling and Cell Therapy [DOI]
  41. 41 Decoding Genetics of Congenital Heart Disease Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs) [DOI]
  42. 42 Energy biotechnology in the CRISPR-Cas9 era [DOI]
  43. 43 Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products [DOI]
  44. 44 CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19 [DOI]
  45. 45 New Therapies to Correct the Cystic Fibrosis Basic Defect [DOI]
  46. 46 691. A Light-Inducible CRISPR/Cas9 System for Control of Endogenous Gene Activation [DOI]
  47. 47 New ‘prime’ genome editor could surpass CRISPR [DOI]
  48. 48 Application of Crispr Technology for the Generation of Biofuels: A Review
  49. 49 Genome-Editing Technologies: Principles and Applications [DOI]
  50. 50 AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, AAAS [DOI]
  51. 51 Philosophical Transactions of the Royal Society B: biological sciences [DOI]
  52. 52 Signal Transduction and Targeted Therapy [DOI]

Cited by 2

Article metrics

Real usage data collected on this platform.

44

Page views

0

PDF downloads

4

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.